Atlas Trials

A Switch Study From High-Sodium Oxybate to Xywav to Evaluate Changes in Blood Pressure in Participants With Narcolepsy

Clinical trial NCT05869773 · COMPLETED

Trial details

NCT number
NCT05869773
Sponsor
Jazz Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Narcolepsy
Start date
2023-06-26
Primary completion
2025-02-25
Enrollment
155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.